Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.05%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 5.47Close
$ 2.42 - $ 5.73 52-Week Range
Ticker Information
Ticker
PBYICompany Name
PUMA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPUMA BIOTECHNOLOGY INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PBYI - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 117K | 0.05% | $ 238.06M |
| 3/31/2025 | $ 117K | 0.05% | $ 232.71M |
| 12/31/2024 | $ 56K | 0.02% | $ 230.47M |
| 9/30/2024 | $ 85K | 0.03% | $ 243.57M |
| 6/30/2024 | $ 92K | 0.04% | $ 219.14M |
| 3/31/2024 | $ 140K | 0.06% | $ 226.63M |
| 12/31/2023 | $ 140K | 0.06% | $ 235.64M |
| 9/30/2023 | $ 95K | 0.04% | $ 229.13M |
| 6/30/2023 | $ 68K | 0.03% | $ 230.12M |
| 3/31/2023 | $ 0 | 0% | $ 235.07M |
Key Performance Insights, Last 5 Years
- PUMA BIOTECHNOLOGY INC's latest trailing twelve months (TTM) CapEx % stands at 0.14%.
- Over the past 5 years, PUMA BIOTECHNOLOGY INC's average CapEx % has been 0.04%.
- The median CapEx % for PUMA BIOTECHNOLOGY INC during this period was 0.04%
- PUMA BIOTECHNOLOGY INC reached its highest CapEx % over the past 5 years at 0.14%.
- The lowest CapEx % recorded by PUMA BIOTECHNOLOGY INC in the same timeframe 0.01%
PUMA BIOTECHNOLOGY INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for PUMA BIOTECHNOLOGY INC is calculated as follows: CapEx [ $ 329K ] / Revenues [ $ 235.47M ]
(=) CapEx % [ 0.14% ] PBYI - Capital Expenditures Margin, Last 5 years
0.01%
Minimum
Sep 30, 2021
0.14%
Maximum
Sep 30, 2020
0.04%
Average
0.04%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.04% |
| average | 3.46% |
| median | 2.43% |
| std | 3.27% |